DanMedica ApS

APSActiveAdvertising protection

CVR 44866188Dirch Passers Allé 22, 2000 FrederiksbergRetail sale of medical and orthopaedic goods· NACE 4774Est. 2024 · 2 years old2 employeeshttps://danmedica.dk

Overview

DanMedica ApS is a Danish APS based in Frederiksberg, operating in the Retail sale of medical and orthopaedic goods sector. Incorporated in 2024, the company has 2 employees and reported a gross profit of DKK 759.8k in its latest annual filing.

Gross profit 2025

759.8K DKK

−2840% vs 2024

EBITDA margin (of gross profit)

5.4 %

+150% vs 2024

Net profit 2025

35K DKK

+143% vs 2024

Key ratios

See full ratios →

-1.7 %

Very weak

Among the 20% lowest rated companies in the industry

20242025

1.0×

Weak

Among the 30% lowest rated companies in the industry

20242025

8.8 %

Strong

Among the 40% highest rated companies in the industry

20242025

EBITDA — year on year

DKK thousands

Key figures

Annual report 2025

Gross profit	759.8K DKK	-2840%
EBITDA	41.1K DKK	+150%
Net profit	35K DKK	+143%
Total assets	397K DKK	+196%
Equity	-6.9K DKK	+84%
Employees	2	—

Contact

Address

Dirch Passers Allé 22, 2000 Frederiksberg

info@danmedica.dk

Website

https://danmedica.dk

Advertising protection

Active — opted out of marketing use

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Financial development

In its most recent annual report (2025), DanMedica ApS reported a gross profit of DKK 759.8k. The figures on this page draw on 2 annual filings covering 2024 to 2025. The bottom line showed a net profit of DKK 35.0k, and the EBITDA margin stood at 5.4%.

At the end of 2025, current assets covered short-term debt 1 times.

Financials

Gross profit

DKK thousands

EBITDA

DKK thousands

Income statement

DKK thousands

Item	2025	2024
Gross profit	760	-28
Staff expenses	-719	-54
EBITDA	41	-82
Depreciation & amort.	-0	-0
EBIT	41	-82
Net financials	-6	-0
Profit before tax	35	-82
Tax	-0	-0
Net profit	35	-82

Get a credit rating – not just the numbers

Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.

See the credit rating

Balance sheet

DKK thousands

Item	2025	2024
Total assets	397	134
Equity	-7	-42
Long-term debt	0	0
Short-term debt	404	176
Total debt	404	176

Financial ratios

5-year trend

EBITDA margin (of gross profit)

5.4 %

20242025

Equity ratio

-1.7 %

Very weak

Among the 20% lowest rated companies in the industry

20242025

Return on equity

—

20242025

Net profit margin (of gross profit)

4.6 %

20242025

Asset turnover (of gross profit)

1.91×

20242025

Debt / equity

—

20242025

Sector performance

16 of 28 ratios graded

28 financial ratios from the latest filing, each graded against companies in the same industry.

Profitability

Return on assets (ROA)Strong

Among the 40% highest rated companies in the industry

Net profit as a percentage of total assets — the return generated on the capital employed.

Basic earning power (BEP)Strong

Among the 40% highest rated companies in the industry

EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.

Capacity ratioWeak

Among the 40% lowest rated companies in the industry

Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.

Gross marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.

Operating marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.

Net profit marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The profit for the year as a share of revenue — the company's ability to turn revenue into profit.

Return on equity (ROE)Not rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Net profit as a percentage of equity — the return the owners earned on their invested capital this year.

Return on net assets (RONA)Not rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.

Liquidity

Current ratioWeak

Among the 30% lowest rated companies in the industry

Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.

Quick ratioAverage

Around the average of companies in the same industry

Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.

Cash ratioStrong

Among the 40% highest rated companies in the industry

Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.

Cash conversion ratioAverage

Around the average of companies in the same industry

Cash flow relative to profit — the ability to convert reported profits into accessible cash.

Current assets to equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.

Fixed assets to long-term capitalNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.

Debt & solvency

Solidity ratioVery weak

Among the 20% lowest rated companies in the industry

Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.

Debt ratioVery weak

Among the 20% lowest rated companies in the industry

Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.

Income to debtAverage

Around the average of companies in the same industry

Profit relative to debt — the ability to create earnings while operating with debt.

EBITDA to debtAverage

Around the average of companies in the same industry

EBITDA relative to debt — how much operating earnings are available to service the debt.

Interest coverageStrong

Among the 40% highest rated companies in the industry

The ability to pay the interest on the company's debt out of its earnings.

Interest rate on debtAverage

Around the average of companies in the same industry

Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.

Interest marginStrong

Among the 30% highest rated companies in the industry

The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.

Debt to equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.

Liabilities to equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.

Efficiency & development

Equity to contributed capitalVery weak

Among the 20% lowest rated companies in the industry

Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.

One-year change in debtVery weak

Among the 10% lowest rated companies in the industry

The size of this year's increase or decrease in the company's debt.

Asset turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to total assets — the ability to generate revenue from the asset base.

Inventory turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.

One-year change in equityNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The size of this year's increase or decrease in the company's equity.

Annual reports & filings

Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-05-01 – 2024-12-31
View PDF

People & ownership

Management

Actively employed in the business

Name	Role	Member since
Current (3)
MO Morten Overgaard Nielsen Chief Executive Officer	Chief Executive Officer	2024
HK Hasse Kvist Simonsen Management	Management	2024
NB Nicolaj Bundgaard Rasmussen Management	Management	2024

Board of directors

Non-executive oversight

No data on file.

Shareholders

Active legal owners

Shareholder	Type	Ownership	Votes	Registered
Morten Overgaard Nielsen	Individual	33.33–49.99%	33.33–49.99%	2024
Hasse Kvist Simonsen	Individual	33.33–49.99%	33.33–49.99%	2024
Nicolaj Bundgaard Rasmussen	Individual	33.33–49.99%	33.33–49.99%	2024

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.

One in three Danish companies experiences fraud

Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.

See the fraud module

Related companies

Company hierarchy

No registered parent or subsidiaries

Board network connections

Board members of DanMedica ApS also hold positions in 3 other companies.

Person	Role here	Other companies
Morten Overgaard Nielsen	Chief Executive Officer	1 company
Hasse Kvist Simonsen	Management	1 company
Nicolaj Bundgaard Rasmussen	Management	1 company

Frequently asked questions

What is the CVR number of DanMedica ApS?

DanMedica ApS is registered with CVR / Virk under CVR 44866188.

What is the gross profit of DanMedica ApS?

DanMedica ApS reported a gross profit of DKK 759.8k in 2025.

How many employees does DanMedica ApS have?

DanMedica ApS employs 2 people as of the latest annual report.

Who is the CEO of DanMedica ApS?

Morten Overgaard Nielsen is the CEO of DanMedica ApS.

Where is DanMedica ApS headquartered?

DanMedica ApS's registered address is Dirch Passers Allé 22.